Listerine, store-brand mouthwashes earn warnings
This article was originally published in The Rose Sheet
Executive Summary
FDA warns Johnson & Johnson, CVS and Walgreen that the firms' respective mouthwash products make unapproved drug claims for sodium fluoride. Warning letters sent Sept. 27 say Listerine Total Care Anticavity Mouthwash, CVS Complete Care Anticavity Mouthwash and Walgreen Mouth Rinse Full Action all claim to "fight visible plaque above the gum line," representing an antiplaque/antigingivitis claim not covered by the OTC Anticavity Final Monograph and not under consideration for sodium fluoride in the proposed monograph for Oral Healthcare Products for Antigingivitis/Antiplaque. FDA says the warnings are part of its "effort to curtail an increasing number of Federal Food, Drug and Cosmetic Act violations" by mouthwash marketers
You may also be interested in...
Listerine suit filed
Class action lawsuit filed Oct. 1 against Johnson & Johnson cites recent FDA warning issued to the manufacturer of Listerine Total Care Anticavity Mouthwash, which according to the agency is marketed on unapproved drug claims. The suit - Britton v. Johnson & Johnson - filed by Scott Cole & Associates, APC, seeks monetary damages and a court order to stop J&J from "further misleading advertising." Listerine Total Care is touted as a 6-in-1 solution for oral hygiene. FDA also targeted CVS (Complete Care Anticavity Mouthwash) and Walgreen (Mouth Rinse Full Action) with warning letters for similar claims, such as "Helps prevent cavities" and "Helps fight visible plaque above the gum line" (1"The Rose Sheet" Oct. 4, 2010, In Brief). J&J "advertises this total care product as an FDA-approved drug that fights gum disease. That's simply not true," says Cole. "In fact, the FDA has gone so far as to direct [J&J] to stop making such false statements. Our lawsuit adds an extra incentive for the company.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.